A Deeper Dive Into Novamind’s Q2 Financial Results

Earlier this week, we reported on Novamind‘s quarterly results. You can read that here.

But we wouldn’t be doing our job if we didn’t dive in deeper.

So here is Adam’s video taking a closer look at Novamind, the market’s sentiment with the news, and comparisons with other industry companies that have made similar moves of late.

Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of integrative mental health clinics and operates a full-service contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit novamind.ca.